Corrigendum to "Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia" [<i>Kidney International Reports</i> Volume 9, Issue 5, May 2024, Pages 1419-1428].
對於「Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia」的更正 [<i>Kidney International Reports</i> 第9卷，第5期，2024年5月，頁1419-1428]。
Kidney Int Rep 2025-02-24
Corrigendum to "WCN24-1051 CLINICAL PROFILE, DIAGNOSIS, THERAPEUTIC INTERVENTION AND COMPLICATIONS IN RENAL BIOPSY IN CKD POPULATION - SINGLE CENTER 20 YEARS' EXPERIENCE" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S86].
對於「WCN24-1051 CLINICAL PROFILE, DIAGNOSIS, THERAPEUTIC INTERVENTION AND COMPLICATIONS IN RENAL BIOPSY IN CKD POPULATION - SINGLE CENTER 20 YEARS' EXPERIENCE」的更正 [<i>Kidney International Reports</i> 第9卷，第4期，補充，2024年4月，第S86頁]。
Kidney Int Rep 2024-07-31
Corrigendum to "The Association Between Metabolic Syndrome, Hyperfiltration, and Long-Term GFR Decline in the General Population" [<i>Kidney International Reports</i> Volume 8, Issue 9, September 2023, Pages 1831-1840].
對於「代謝症候群、高過濾率與一般人群長期GFR下降之間的關聯」的更正 [<i>Kidney International Reports</i> 第8卷，第9期，2023年9月，頁1831-1840]。
Kidney Int Rep 2024-07-31
Corrigendum to "WCN24-1267 EMPAGLIFLOZIN IMPROVES VITALITY AND PROTECT FROM ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S637].
對於「WCN24-1267 EMPAGLIFLOZIN 改善活力並保護內皮細胞免受高級糖化終產物的影響」的更正 [<i>Kidney International Reports</i> 第9卷，第4期，補充，2024年4月，第S637頁]。
Kidney Int Rep 2024-07-31
Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [<i>Kidney International Reports</i> Volume 6, Issue 4, April 2021, Pages 1183-1188].
對於「Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy」的更正 [<i>Kidney International Reports</i> 第6卷，第4期，2021年4月，頁1183-1188]。
Kidney Int Rep 2024-07-31
Corrigendum to "Nitric Oxide Precursors and Dimethylarginines as Risk Markers for Accelerated Measured GFR Decline in the General Population" [<i>Kidney International Reports</i> Volume 8, Issue 4, April 2023, Pages 818-826].
對於「Nitric Oxide Precursors and Dimethylarginines as Risk Markers for Accelerated Measured GFR Decline in the General Population」的更正 [<i>Kidney International Reports</i> 第8卷，第4期，2023年4月，頁818-826]。
Kidney Int Rep 2024-07-31
Corrigendum to "WCN24-660 Comparative Analysis of High Flux and Low Flux Dialysis Membranes: In-Situ Synchrotron Imaging and Experimental Ex-Vivo Studies" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S363].
對於「WCN24-660 高通量與低通量透析膜的比較分析：原位同步輻射成像及實驗性體外研究」的更正 [<i>Kidney International Reports</i> 第9卷，第4期，補充，2024年4月，第S363頁]。
Kidney Int Rep 2024-08-19
看起來你提到的是一篇有特定 DOI 的文章的更正。如果你需要幫助理解這個更正、總結文章內容，或是有其他相關的問題，請提供更多細節！
PubMedDOI
Corrigendum to "WCN24-1709 NON-CADAVERIC HOMOLOGOUS VEIN AS VASCULAR ACCESS IN A PATIENT WITH EXHAUSTED NATIVE VEINS ON HEMODIALYSIS" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Pages S398-S399].
對於「WCN24-1709 非屍體同源靜脈作為一名在透析中原生靜脈耗竭患者的血管通路」的更正 [<i>Kidney International Reports</i> 第9卷，第4期，補充，2024年4月，頁S398-S399]。
Kidney Int Rep 2024-08-19
Corrigendum to "WCN24-2499 CAVEOLIN-1 AND CAVEOLIN-2 AS POTENTIAL URINARY EARLY BIOMARKERS OF RENAL INJURY IN ACUTE CHOLESTASIS IN RATS" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S541].
對於「WCN24-2499 CAVEOLIN-1 和 CAVEOLIN-2 作為急性膽汁淤積大鼠腎損傷的潛在尿液早期生物標記」的更正 [<i>Kidney International Reports</i> 第9卷，第4期，補充，2024年4月，第S541頁]。
Kidney Int Rep 2024-08-19
Corrigendum to "WCN24-813 MANAGEMENT OF ACUTE FLUID OVERLOAD IN HEART FAILURE PATIENTS WITH CKD USING HOME DELIVERED SUBCUTANEOUS FUROSEMIDE" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S251-S252].
對於「WCN24-813 心衰竭合併慢性腎病患者急性液體過載的管理：使用居家配送的皮下注射 Furosemide」的更正 [<i>Kidney International Reports</i> 第9卷，第4期，補充，2024年4月，頁S251-S252]。
Kidney Int Rep 2024-09-18
看起來你提到的是一篇有特定 DOI 的文章的更正。如果你需要幫助理解這個更正、總結文章內容，或是其他相關的問題，請提供更多細節！
PubMedDOI